CA-JUNIPER-NETWORKS
11.3.2024 20:26:32 CET | Business Wire | Press release
Juniper Networks (NYSE: JNPR), a leader in secure AI-Native Networking, today announced that Gartner, Inc. has named it a Leader in the 2024 Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure for the fourth time in a row. In the latest iteration of this Magic Quadrant, for the third time straight, Juniper is also positioned furthest in “Completeness of Vision,” a Gartner rating criterion that reflects innovation, and evaluates vendors on their ability to communicate that they understand client business issues in their target markets and have the products, services, vision and strategies to address these issues. In addition, Juniper was once again positioned highest for “Ability to Execute,” a Gartner rating criterion that evaluates vendors on their product/service, market responsiveness and customer experience.
As Gartner explains, “Magic Quadrants offer visual snapshots, in-depth analyses and actionable advice that provide insight into a market’s direction, maturity and participants. Assessing the market and its technology and service providers is a business-critical task. Vendor differentiation based on variations in operations, customer satisfaction, level of complexity and strategy can make comparisons of vendor offerings challenging. In addition, the market’s overall direction is often evolving. Gartner’s Magic Quadrants solve these problems by offering snapshots of markets and their participants, and help you map vendor strengths and cautions against your current and future needs.”
“We believe this latest recognition as a Leader by Gartner reinforces the value our products deliver for our customers,” said Sudheer Matta, Group Vice President, Products for the AI-Native Enterprise, Juniper Networks. “By delivering full-stack automation, insight and self-driving actions, Mist AI continues to stand out from the rest of the industry for fast deployments, the fewest tickets and quickest problem resolution. The momentum we are seeing is a true testament to our vision to design the industry’s first AI-Native Networking Platform from the ground up to provide reliable and consistent Wi-Fi experiences. By using automation to reduce or eliminate time-consuming manual tasks, and implementing automated workflows to proactively fix issues before they impact users, we consistently deliver proven value, saving substantial time and money for our customers and partners worldwide.”
In addition, Juniper recently announced record 2023 revenue results, marking the third consecutive year of business growth on a year-over-year basis. Juniper’s AI-Native enterprise solutions significantly outpaced the market, with revenue from wired and wireless access products attached to the Mist cloud growing nearly 70% on a full-year basis.
And as reported by the 650 Group Wireless LAN Infrastructure Quarterly Market & Long-Term Forecast Report 4Q23, published on March 1, 2024, while most of the industry contracted in Q4, Juniper continued its strong growth both Q/Q and Y/Y. In addition, Juniper was the fastest growing vendor on a full calendar year basis from 2022 to 2023.
Juniper solutions are deployed and helping drive better connections in 4 of the Fortune 10, 3 of the top-3 retailers, 2 of the top-5 Fintech companies, top Global universities, and the #1 healthcare provider in the United States. And Juniper’s public customer wins continue to expand across all verticals, with a host of new public success stories, including:
James Cook University Singapore
Juniper’s recognition in the Magic Quadrant for latest Enterprise Wired and Wireless LAN Infrastructure report is in addition to Gartner also recently naming Juniper Networks a Leader in the 2024 Gartner Magic Quadrant for Indoor Location Services for the third year in a row.
As the only vendor named a Leader in both the Wired and Wireless LAN Infrastructure and Indoor Location Services Magic Quadrant reports, Juniper believes its solutions are uniquely positioned to deliver exceptional experiences for both operators and end users. Automation in Juniper’s wired and wireless solutions not only helps accelerate deployments and eliminate up to 90% of networking-related trouble tickets, but our indoor location services offer customers and partners a scalable and cost-effective way to personalize wireless experiences with value-added features like wayfinding, asset location, and contextual notifications.
Additional Resources
- 2024 Gartner Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure: View Report
- Blog: Juniper’s Fourth Time in a Row: A Leader in the 2024 Gartner® Magic Quadrant™ for Enterprise Wired and Wireless LAN Infrastructure
- 2024 Gartner Magic Quadrant for Indoor Location Services: View Report
- Blog: Three Years in a Row: Juniper Networks® Once Again Named a Leader in the 2024 Gartner® Magic Quadrant™ for Indoor Location Services
- Juniper industry recognition: Learn more
Gartner Disclaimer
Gartner, Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure, Tim Zimmerman, Christian Canales, Nauman Raja, Mike Leibovitz 6 March 2024.
Gartner Magic Quadrant for Indoor Location Services, Global, Tim Zimmerman, Annette Zimmermann, et al., 28 February 2024.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Juniper Networks is recognized as Juniper in the 2024, 2022, and 2021 Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure reports.
About Juniper Networks
Juniper Networks believes that connectivity is not the same as experiencing a great connection. Juniper's AI-Native Networking Platform is built from the ground up to leverage AI to deliver the best and most secure user experiences from the edge to the data center and cloud. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on X (Twitter) LinkedIn and Facebook.
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240311703596/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom